Tsuchida A - Search Results

1

Inhibition of thromboxane A2 synthetase failed to limit myocardial infarct size in a rabbit ischemia-reperfusion model.

Tsuchida A, Miura T, Ogawa T, Iwamoto T, Shimamoto K, Iimura O. Tsuchida A, et al. Jpn Circ J. 1991 Feb;55(2):174-83. doi: 10.1253/jcj.55.174. Jpn Circ J. 1991. PMID: 2020088

2

Effect of anoxic preperfusion on ischemic myocardial injury in isolated rat hearts.

Noto T, Miura T, Urabe K, Endoh A, Tsuchida A, Iimura O. Noto T, et al. Among authors: tsuchida a. Jpn Heart J. 1992 Sep;33(5):679-91. doi: 10.1536/ihj.33.679. Jpn Heart J. 1992. PMID: 1289598

3

Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning.

Tsuchida A, Miura T, Miki T, Shimamoto K, Iimura O. Tsuchida A, et al. Cardiovasc Res. 1992 May;26(5):456-61. doi: 10.1093/cvr/26.5.456. Cardiovasc Res. 1992. PMID: 1446315

4

Myocardial infarct size-limiting effect of ischemic preconditioning was not attenuated by oxygen free-radical scavengers in the rabbit.

Iwamoto T, Miura T, Adachi T, Noto T, Ogawa T, Tsuchida A, Iimura O. Iwamoto T, et al. Among authors: tsuchida a. Circulation. 1991 Mar;83(3):1015-22. doi: 10.1161/01.cir.83.3.1015. Circulation. 1991. PMID: 1999006

5

Does verapamil limit myocardial infarct size in a heart deficient in xanthine oxidase?

Adachi T, Miura T, Noto T, Ooiwa H, Ogawa T, Tsuchida A, Iwamoto T, Goto M, Iimura O. Adachi T, et al. Among authors: tsuchida a. Clin Exp Pharmacol Physiol. 1990 Nov;17(11):769-79. doi: 10.1111/j.1440-1681.1990.tb01279.x. Clin Exp Pharmacol Physiol. 1990. PMID: 2078905

6

Tissue-type plasminogen activator alone or in combination with thromboxane A2 synthetase inhibitor for ischemic myocardium.

Ogawa T, Miura T, Tsuchida A, Iwamoto T, Urabe K, Endoh A, Iimura O. Ogawa T, et al. Among authors: tsuchida a. Can J Cardiol. 1990 Oct;6(8):361-6. Can J Cardiol. 1990. PMID: 2125235

7

The effect of inotropic dose of dobutamine during reperfusion on myocardial infarct size.

Ooiwa H, Miura T, Downey JM, Matsuki T, Shizukuda Y, Adachi T, Tsuchida A, Iwamoto T, Ogawa T, Iimura O. Ooiwa H, et al. Among authors: tsuchida a. Jpn Circ J. 1989 Dec;53(12):1511-20. doi: 10.1253/jcj.53.1511. Jpn Circ J. 1989. PMID: 2632820

8

Infarct-size limitation by preconditioning is enhanced by dipyridamole administered before but not after preconditioning: evidence for the role of interstitial adenosine level during preconditioning as a primary determinant of cardioprotection.

Suzuki K, Miura T, Miki T, Tsuchida A, Shimamoto K. Suzuki K, et al. Among authors: tsuchida a. J Cardiovasc Pharmacol. 1998 Jan;31(1):1-9. doi: 10.1097/00005344-199801000-00001. J Cardiovasc Pharmacol. 1998. PMID: 9456270

9

Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation.

Miki T, Miura T, Tsuchida A, Nakano A, Hasegawa T, Fukuma T, Shimamoto K. Miki T, et al. Among authors: tsuchida a. Circulation. 2000 Jul 25;102(4):458-63. doi: 10.1161/01.cir.102.4.458. Circulation. 2000. PMID: 10908220

10

Endothelium-dependent coronary response is impaired in the myocardium at an early phase of post-infarct remodeling.

Hasegawa T, Miura T, Tsuchida A, Miki T, Nakano A, Kuno A, Shimamoto K. Hasegawa T, et al. Among authors: tsuchida a. Jpn Heart J. 2000 Nov;41(6):743-55. doi: 10.1536/jhj.41.743. Jpn Heart J. 2000. PMID: 11232991 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

678 results

Search Page

Filters